Target intelligence / Profile preview

SLC24A3 antisense RNA 1 (SLC24A3-AS1)

Target: SLC24A3-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

SLC24A3 antisense RNA 1 (SLC24A3-AS1) is a long non-coding RNA gene located on the opposite strand of the SLC24A3 locus (chr20:19242302-19284596, hg38), annotated in sources such as NCBI and Ensembl [4][7]. SLC24A3-AS1 does not encode a protein but is classified as an lncRNA, specifically an antisense RNA, meaning it is transcribed in the opposite direction to the protein-coding SLC24A3 gene [6][7]. Currently, there are no clearly established therapeutic roles, interacting drugs, or recognized mechanisms of action for SLC24A3-AS1. Its primary putative function is gene regulation via antisense mechanisms, possibly influencing SLC24A3 expression or chromatin state, but there are no detailed studies delineating disease associations or functional pathways for this RNA. If you intended SLC9A3-AS1, a similarly named lncRNA with cancer associations, this is a different gene and not related to SLC24A3 antisense RNA 1 [3].

Other names: SLC24A3-AS1

Biological functions

Regulation of gene expression (particularly in a cis-antisense manner)

Disease associations

Other (potential biomarker or molecular role in gene expression in specific tissues or pathologies has not been well characterized)

Beyond the preview

Go deeper on SLC24A3 antisense RNA 1 (SLC24A3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLC24A3 antisense RNA 1 (SLC24A3-AS1).

Explore the full profile